Findings demonstrated that characteristics of systemic inflammation in obesity, including elevated pro-inflammatory cytokine production (TNF-α and IL-6) and upregulated NF-κB-related genes (NFKB1 and RELA), present in obesity were reduced by significant weight loss and ex vivo SCFA treatment. This evidence concerns the gene IL6 and obesity disorder.